Craig Tracey
Main Page: Craig Tracey (Conservative - North Warwickshire)Department Debates - View all Craig Tracey's debates with the Leader of the House
(1 month, 1 week ago)
Commons ChamberRead Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Penny Mordaunt
Like many hon. Members from across the House, I have cases of this kind in my constituency, and have been working to support the individuals involved. I reiterate the Government’s position, which is that I am sure the Secretary of State for Work and Pensions will want to update the House at the earliest occasion. He will clearly have to read the report and reflect on it, but I know that he is keen to do so swiftly.
Craig Tracey (North Warwickshire) (Con)
This week, I had the privilege of meeting the inspirational Hannah Gardner, who has incurable secondary breast cancer at the age of just 37. Recently, Hannah and thousands of other women received the devastating news that the life-extending drug Enhertu, described by oncologists as a game-changer, has been rejected by the National Institute for Health and Care Excellence for use by the NHS in England, despite being approved in Scotland and 45 other countries worldwide. She brought a campaign to Parliament, because it is the only realistic treatment available for her, and time is not on her side. Can we have an urgent debate on getting all parties, including the drug companies, NICE and NHS England, back to the table, and urgently approving Enhertu, so that Hannah can at least realise her modest wish of seeing her three-year-old daughter Lilah attend her new school?
Penny Mordaunt
I thank my hon. Friend for all his campaigning in this area, and for all his work with a number of all-party parliamentary groups. I also thank him for arranging for me to meet Hannah when she visited Parliament. She is an inspirational woman, and the fact that she is campaigning so hard, not just for herself but for other people, is testament to that. I also thank the Breast Cancer Now team, who also visited me and are doing tremendous work in campaigning to ensure that not just Enhertu but other life-extending drugs can be approved.
I am sure that the Secretary of State for Health and Social Care will have heard about the campaign and will want to set up meetings to discuss it. I think that about 1,000 women a year in England could benefit from the drug, and given that it is widely available and deemed to be clinically and cost-effective elsewhere, I hope that NICE will reflect on that, and that a patient access scheme might be established. I will ensure that the Secretary of State has heard what my hon. Friend said.